Skip to main content

Table 4 Bivariate and multivariable Accelerated Failure Time model estimates of the survival time within 30 days after the onset of infection among patients infected with K. pneumoniae

From: Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study

Variables

Survivors (n = 276)

Non-survivors (n = 62)

Relative times (95% CI)

Adjusted relative times (95% CI)

n

%

n

%

CRKP infection

33

11.96

16

25.81

0.42 (0.22–0.76)

0.44 (0.24–0.84)

Male sex

161

58.33

37

59.68

0.91 (0.55–1.49)

Age in years (median, IQR)

65

(51–76)

71

(55–78)

0.99 (0.97–1.00)

0.99 (0.98–1.01)

Transfer from another facility

103

37.32

26

41.94

1.21 (0.74–1.96)

ICU hospitalization

31

11.23

20

32.26

0.61 (0.33–1.13)

0.77 (0.41–1.45)

Mechanical ventilation

23

8.33

13

20.97

0.92 (0.46–1.83)

Charlson Index score (median, IQR)

4

(2–6)

4

(3–6)

0.92 (0.84–1.01)

0.90 (0.78–1.03)

Healthcare associated infection

103

41.53

33

58.93

0.58 (0.34–0.98)

0.72 (0.40–1.30)

Surgical treatment

81

29.35

19

30.65

1.22 (0.73–2.05)

Type of infection

 UTI-CAUTI

109

39.49

11

17.74

reference

 

 Pneumonia

17

6.16

7

11.29

0.58 (0.22–1.48)

0.54 (0.20–1.44)

 Bloodstream infection

32

11.59

16

25.81

0.52 (0.24–1.11)

0.58 (0.24–1.38)

 Surgical site infection

24

8.70

8

12.90

0.62 (0.25–1.54)

0.87 (0.32–2.40)

 Intra-abdominal

56

20.29

17

27.42

0.53 (0.26–1.05)

0.45 (0.21–0.94)

 Other

38

13.77

3

4.84

2.44 (0.88–6.76)

1.93 (0.68–5.46)